LITTLETON, Colo.--(BUSINESS WIRE)--Aug. 4, 2005--Zynex Medical Holdings, Inc. (OTCBB: ZYNX), a provider of pain management systems and electrotherapy products for medical patients with functional disability, today announced the expansion of marketing efforts of its NeuroMove(TM) Stroke Recovery System to major stroke rehabilitation facilities across the US. “Until now most of our revenue for the NeuroMove has largely resulted from visits to the product’s website (www.neuromove.com), which averages more than 100,000 hits per month,” stated President and Chief Executive Officer Thomas Sandgaard. “Our marketing efforts have proven successful at stroke rehabilitation centers in Rochester, Minn., and St. Louis, Mo., and we are beginning to increase our activity on a nationwide basis. Our center program is particularly attractive because it provides physicians the NeuroMove and enables them to evaluate patients in the clinic and to qualify those patients for home use of the our flagship product.”
